Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Multiparametric flow cytometry analysis of peripheral blood B cell trafficking differences among Epstein-Barr virus infected and uninfected subpopulations

K. Zachova, P. Kosztyu, J. Zadrazil, K. Matousovic, K. Vondrak, P. Hubacek, K. Kostovcikova, H. Tlaskalova Hogenova, J. Mestecky, M. Raska

. 2020 ; 164 (3) : 247-254. [pub] 20191012

Language English Country Czech Republic

Document type Comparative Study, Journal Article

Persistent link   https://www.medvik.cz/link/bmc21021183

AIMS: Epstein-Barr virus (EBV) targets predominantly B cells and these cells could acquire new phenotype characteristics. Here we analyzed whether EBV-infected and -uninfected B cells from healthy subjects differ in proportion of dominant phenotypes, maturation stage, and homing receptors expression. METHODS: EBV-infected and -uninfected cells were identified by flow cytometry using fluorophore-labeled EBV RNA-specific DNA probes combined with fluorophore-labeled antibody to surface lineage markers, integrins, chemokine receptors, and immunoglobulin isotypes, including intracellular ones. RESULTS: Our results show that the trafficking characteristics of EBERpos B cells are distinct from EBERneg B cells with most dominant differences detected for α4β1 and α4β7 and CCR5 and CCR7. EBV-positive cells are predominantly memory IgM+ B cells or plasmablasts/plasma cells (PB/PC) positive for IgA or less for IgM. In comparison to uninfected B cells, less EBV-positive B cells express α4β7 and almost no cells express α4β1. EBV-positive B cells contained significantly higher proportion of CCR5+ and CCR7+ cells in comparison to EBV-negative cells. In vitro exposure of blood mononuclear cells to pro-inflammatory cytokine IL-6 reduces population of EBV-positive B cell. CONCLUSION: Although EBV-infected B cells represent only a minor subpopulation, their atypical functions could contribute in predisposed person to development abnormities such as some autoimmune diseases or tumors. Using multi-parameter flow cytometry we characterized differences in migration of EBV-positive and -negative B cells of various maturation stage and isotype of produced antibodies particularly different targeting to mucosal tissues of gastrointestinal and respiratory tracts.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21021183
003      
CZ-PrNML
005      
20210916103934.0
007      
ta
008      
210806s2020 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2019.052 $2 doi
035    __
$a (PubMed)31723302
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Zachová, Kateřina $7 xx0253002 $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
245    10
$a Multiparametric flow cytometry analysis of peripheral blood B cell trafficking differences among Epstein-Barr virus infected and uninfected subpopulations / $c K. Zachova, P. Kosztyu, J. Zadrazil, K. Matousovic, K. Vondrak, P. Hubacek, K. Kostovcikova, H. Tlaskalova Hogenova, J. Mestecky, M. Raska
504    __
$a Literatura
520    9_
$a AIMS: Epstein-Barr virus (EBV) targets predominantly B cells and these cells could acquire new phenotype characteristics. Here we analyzed whether EBV-infected and -uninfected B cells from healthy subjects differ in proportion of dominant phenotypes, maturation stage, and homing receptors expression. METHODS: EBV-infected and -uninfected cells were identified by flow cytometry using fluorophore-labeled EBV RNA-specific DNA probes combined with fluorophore-labeled antibody to surface lineage markers, integrins, chemokine receptors, and immunoglobulin isotypes, including intracellular ones. RESULTS: Our results show that the trafficking characteristics of EBERpos B cells are distinct from EBERneg B cells with most dominant differences detected for α4β1 and α4β7 and CCR5 and CCR7. EBV-positive cells are predominantly memory IgM+ B cells or plasmablasts/plasma cells (PB/PC) positive for IgA or less for IgM. In comparison to uninfected B cells, less EBV-positive B cells express α4β7 and almost no cells express α4β1. EBV-positive B cells contained significantly higher proportion of CCR5+ and CCR7+ cells in comparison to EBV-negative cells. In vitro exposure of blood mononuclear cells to pro-inflammatory cytokine IL-6 reduces population of EBV-positive B cell. CONCLUSION: Although EBV-infected B cells represent only a minor subpopulation, their atypical functions could contribute in predisposed person to development abnormities such as some autoimmune diseases or tumors. Using multi-parameter flow cytometry we characterized differences in migration of EBV-positive and -negative B cells of various maturation stage and isotype of produced antibodies particularly different targeting to mucosal tissues of gastrointestinal and respiratory tracts.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a B-lymfocyty $x imunologie $7 D001402
650    _2
$a krev $x imunologie $7 D001769
650    _2
$a infekce virem Epsteina-Barrové $x imunologie $x patofyziologie $7 D020031
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a průtoková cytometrie $7 D005434
650    _2
$a zdraví dobrovolníci pro lékařské studie $7 D064368
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a vezikulární transportní proteiny $x imunologie $x metabolismus $7 D033921
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kosztyu, Petr $7 xx0239748 $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
700    1_
$a Zadražil, Josef, $d 1954- $7 xx0074493 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
700    1_
$a Matoušovic, Karel, $d 1940-2021 $7 jn19990216123 $u Department of Internal Medicine, 2nd Faculty Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
700    1_
$a Vondrák, Karel $7 xx0260300 $u Department of Pediatrics, 2nd Faculty Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
700    1_
$a Hubáček, Petr, $d 1978- $7 xx0075829 $u Department of Microbiology, 2nd Faculty Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
700    1_
$a Kostovčíková, Klára $7 xx0264110 $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Tlaskalová, Helena, $d 1938- $7 jn20000402365 $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Městecký, Jiří, $d 1941- $7 nlk20050164024 $u Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA $u Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Raška, Milan, $d 1967- $7 xx0060585 $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic $u Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 164, č. 3 (2020), s. 247-254
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31723302 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20210806 $b ABA008
991    __
$a 20210916103931 $b ABA008
999    __
$a ok $b bmc $g 1694790 $s 1141636
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 164 $c 3 $d 247-254 $e 20191012 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20210806
Back

Find record

Citation metrics

Archiving options